Boehringer Ingelheim Recalls Oxcarbazepine Oral Suspension Due to Resuspension Issues
Boehringer Ingelheim is recalling 10,267 bottles of Oxcarbazepine Oral Suspension because the product failed to meet resuspendability requirements.
- Product
- Oxcarbazepine Oral Suspension, 300 mg/5 mL, 250 mL bottle, Rx only, Boehringer Ingelheim, Roxane Laboratories, Inc. Columbus, Ohio 43216, NDC 0054-0199-59
- Category
- Drug
- Distribution
- Distributed nationwide